Mr Patel, Prash

Prashant Patel qualified in 1993 from India and then trained to qualify as a General Surgeon with a special interest in pelvic surgery. He was awarded a PhD from the University of Birmingham whilst training as a Urologist. He travelled to Perth (2010), Australia to complete a fellowship in urological cancer surgery where he had exposure to laparoscopic and robotic surgery. He has professional registration with the UK, India, USA, Australia, and the Fellowship with European Board of Urology.  He was appointed as a Senior Lecturer in Urology at the University of Birmingham and Consultant Urological Surgeon at QE Hospital (UHB), Birmingham (2010) to pursue a joint career in academic and clinical urology. He was an Associate Professor of Urology and the Head of Department (Clinical Service Lead) 2019 - 2022 at the University Hospitals Birmingham (QE Hospital, Heartlands, Good Hope and Solihull Hospitals) where he led the service amalgamation, instituted robotic surgery at Solihull, appointed 9 consultants and restructured provision of Urology services across Birmingham during the Pandemic. He was headhunted by University College London Hospitals and Royal National Orthopaedic Hospital Stanmore to lead on advanced Pelvic and retro-peritoneal surgery in Jan 2023. He is also the Urology Governance lead at UCLH and is currently awarded a scholarship towards an executive health MBA at UCL.  He is an accredited trainer and educational supervisor by the General Medical Council. He has been on the committee of National Urology Trainee selection since 2011. He is on the teaching faculty at the British Association of Urological Surgeons for the FRCS (Urology) Examinations. His international profile includes panellist and Chair on Bladder Cancer at the European Urology Annual Meetings over several years, Member of the Scientific Evaluation Committee for Translational Cancer Research at the French National Cancer Institute, and Frontiers Guest Associate Editor in Genitourinary Oncology. He is on the board of directors for the ManVan Charity and regularly participates in fundraising and raising awareness for Prostate, Bladder and Testicular cancers at several charity and BAME events.  His academic interests are exploring molecular markers in bladder cancer, immunotherapeutic approaches in all urological cancers and informatics. He is extensively published with >130 peer-reviewed articles in journals and book chapters. He is the Chief Investigator on Gene therapy clinical trial and is also a Principal investigator in several prostate and bladder cancer studies. He is a grant holder of several trials and studies. His research interests are also outside the field of Urology involving large datasets (informatics) where his team explore disease and outcome trends. This area of research has also led to recommendations in national guidance.

His clinical interests are in pelvic cancers (bladder and prostate) and RPLND for metastatic testicular cancer. He conducts cancer surgery ranging from routine straightforward cases to the highly complex and technically demanding operations. He mostly performs multi-speciality complex operations of the genito-urinary tract involving other specialities viz. Colo-rectal/Bowel, Sarcoma (Soft tissue and bone cancers), Gynaecology cancers, Complex Deep Endometriosis and Obstetrics (Placenta Accreta/Percreta).